Genetic Technologies Limited (NASDAQ:GENE) Short Interest Update

Genetic Technologies Limited (NASDAQ:GENE) was the target of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 25,900 shares, a growth of 48.0% from the October 15th total of 17,500 shares. Based on an average daily volume of 15,700 shares, the days-to-cover ratio is presently 1.6 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Genetic Technologies stock. BNP Paribas Financial Markets acquired a new position in shares of Genetic Technologies Limited (NASDAQ:GENE) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 9,100 shares of the biotechnology company’s stock, valued at approximately $26,000. BNP Paribas Financial Markets owned about 0.24% of Genetic Technologies as of its most recent SEC filing. Institutional investors own 0.63% of the company’s stock.

Genetic Technologies Stock Performance

Genetic Technologies stock remained flat at $0.77 during midday trading on Friday. Genetic Technologies has a fifty-two week low of $0.67 and a fifty-two week high of $3.77. The company has a current ratio of 0.88, a quick ratio of 0.83 and a debt-to-equity ratio of 0.01. The company has a 50 day moving average price of $0.77 and a 200-day moving average price of $1.20.

Genetic Technologies Company Profile

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates through AffinityDNA, EasyDNA, and GeneType/Corporate segments.